Gene Query: WNT5A

Dataset Description Geneva Score
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 118.76
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 105.21
RNA sequencing analysis of human embryonic stem cells and axial progenitors 102.67
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 101.31
Effect of Hotair overexpression in human breast cancer cell lines 98.14
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 88.86
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 86.28
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 85.88
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 78.64
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 77.76
IDH3a KO RNA-seq 73.88
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 72.23
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 71.76
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 68.13
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 67.98
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 67.55
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 63.74
circRNA-sequencing 62.32
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 61.78
Disruption of the exocyst induces podocyte loss and dysfunction 61.76
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 61.09
Global analyses of the effect of different cellular contexts on microRNA targeting 61.09
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 59.66
RNA-Seq from early time points in the kidney differentiation protocol 56.7
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 54.48
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 53.9
Identification of the role of polydom in neurofibromas 51.9
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 51.75
RNA-seq of cells with TET1 knockout 51.37
RNA expression following TMPRSS11B overexpression or depletion 51.18
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 50.71
RNA sequencing of mechanically strained NHEKs and control NHEKs 50.47
Paxillin regulates genomic networks in prostate cancer [C4-2] 50.05
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 47.9
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 47.9
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 47.81
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 47.7
Evolution of a transcriptional regulator from a transmembrane nucleoporin 45.27
RNA-seq in HepG2 and IMR90 cells 45.27
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 45.14
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 44.96
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 44.95
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 44.73
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 43.98
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 43.98
MicroRNA targetome analysis during HCMV infection 43.68
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 43.18
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 42.8
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 42.28
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 42.13
High level DNA repair gene expression in human ES cells 42.07
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 41.36
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 40.91
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 40.68
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 40.55
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 40.47
Global expression profiles in cardiac progenitor cells generated by ISX-9 40.47
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 40.39
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 40.38
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 40.38
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 40.26
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 40.15
Maturation of human iNSCs 39.52
Differential expression of genes in AD169-infected MRC5. 39.5
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 38.98
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 38.96
Investigation about fibroblasts of different origins in culture 38.88
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 38.79
Global transcriptome analysis of HAP1 cells 38.09
TFAP2C signalling in human fibroblasts 37.15
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 36.97
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 36.86
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 36.15
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 35.86
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 35.65
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 34.91
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 34.91
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 34.28
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 34.19
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 33.97
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 33.26
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 33.17
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 32.97
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 32.97
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 32.88
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 32.77
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 32.76
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 32.74
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 32.56
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 32.3
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 32.23
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 32.19
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 32.19
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 31.49
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 31.22
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 31.18
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 30.79
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 30.53
Nucleoporin-mediated regulation of cell identity genes 30.52
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 30.05
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 29.87
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 29.81
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 29.79
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 29.79
Inhibition of TNBC metastasis by Gpx1 29.77
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 29.65
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 29.65
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 29.32
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 29.11
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 28.99
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 28.97
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 28.87
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 28.84
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 28.82
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 28.82
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 28.51
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 28.37
Next Generation Sequencing of human SMA and healthy control Motor Neurons 28.32
High-efficiency RNA-based reprogramming of human primary fibroblasts 28.15
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 28.15
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 28.14
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 28.1
MeRIP-seq for heat shock in B-cell lymphoma cells 27.96
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 27.85
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 27.48
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 27.35
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 27.18
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 27.18
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 26.79
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 26.61
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 25.85
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 25.73
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 25.32
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 25.28
Generation and functional characterization of MDSC-like cells 25.25
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 25.04
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 25.01
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 24.98
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 24.89
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 24.54
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 24.35
6mer seed toxicity in tumour suppressive microRNAs 24.17
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 24.1
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 23.94
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 23.9
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 23.78
Tumor exosome integrins determine organotropic metastasis 23.64
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 23.62
Genome-wide Analysis of Chromatin Interactions in Human Cells 23.61
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 23.55
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 23.55
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 23.41
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 23.15
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 23.14
Genome-wide transcriptional response to random aneuploidy in human cells 23.1
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 22.86
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 22.86
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 22.29
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 22.23
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 22.11
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 21.85
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 21.85
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 21.79
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 21.66
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 21.66
Genome wide expression change by RNF168 knocking down in NEC cells 21.33
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 21.26
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 21.24
Transcriptome analysis of Zika infected neural stem cells 21.24
Zika infected neural stem cells 21.24
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 21.0
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 20.89
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 20.79
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 20.7
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 20.63
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 20.62
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 20.62
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 20.5
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 20.5
MEIS1 regulates hematopoiesis in hPSCs 20.38
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 20.28
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 20.17
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 20.02
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 20.02
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 20.0
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 20.0
RNA-seq analyisis of PUM2 knockout cells 19.77
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 19.72
Ectoderm specification of H1 human embryonic stem cells 19.61
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 19.57
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 19.51
Androgen Receptor-regulated genes in prostate cancer cells 19.24
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 19.24
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 19.0
hTERT promotes cell adhesion and migration independent of telomerase activity 18.92
Role of COP1 on MAP kinase transcriptional output in melanoma 18.88
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 18.76
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 18.7
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 18.68
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 18.65
Transcriptome analysis of virus infected tissues 18.52
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 18.34
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 18.26
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 18.26
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 18.21
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 18.19
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 18.14
Gene expression profiling of human and murine in vitro muscle differentiation 18.13
Role of CD133 molecule in WNT response and renal repair 18.11
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 18.02
Transcriptional responses of melanoma cells to BRAF inhibition 17.97
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 17.91
STRIPAK directs PP2A activity to promote oncogenic transformation 17.91
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 17.84
Transcriptome analyses of human pancreatic islets and pseudoislets 17.72
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 17.56
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 17.56
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 17.4
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 17.4
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 17.3
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 17.26
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 17.23
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 17.23
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 17.18
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 17.14
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 16.99
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 16.99
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 16.98
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 16.97
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 16.97
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 16.88
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 16.87
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 16.86
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 16.86
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 16.78
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 16.68
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 16.67
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 16.62
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 16.62
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 16.53
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 16.53
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 16.49
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 16.48
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 16.48
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 16.16
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 16.14
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  16.1
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 16.1
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 16.06
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 16.06
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 16.04
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 16.04
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 16.04
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 15.93
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 15.92
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 15.89
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 15.81
Gene profiling of human adult and pediatric liver cancer cells 15.78
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 15.66
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 15.48
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 15.48
Effect of disulfiram treatment on pediatric high grade glioma 15.37
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 15.32
Role of microRNAs in the interaction between Salmonella and the host cell 15.31
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 15.3
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 15.11
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 15.11
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 15.11
Gene expression profile in breast cancer cell lines using RNA sequencing 15.03
Differential gene expression in Jagged1 treated human dental pulp cells. 14.98
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 14.87
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 14.8
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 14.75
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 14.67
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 14.57
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 14.54
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 14.53
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 14.52
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 14.47
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 14.4
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 14.27
Nonpregnant and term pregnant human myometrial tissues 14.27
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 14.2
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 14.2
RNA-seq of MCF10A cells and CAF 14.15
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 13.88
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 13.88
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 13.75
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 13.74
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 13.74
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 13.67
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 13.66
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 13.62
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 13.6
NKX2.2 13.51
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 13.51
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 13.35
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 13.32
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 13.32
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 13.23
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 13.06
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 13.03
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 13.02
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 12.96
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 12.95
Postnatal lipids drive hepatocyte maturation 12.94
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 12.75
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 12.75
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 12.74
RNA-sequencing in immortalized human mammary epithelial cells 12.69
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 12.69
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 12.63
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 12.63
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 12.51
Modeling Familial Cancer with iPSC Approaches 12.37
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 12.28
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 12.27
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 12.24
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 12.2
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 12.15
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 12.01
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 12.01
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 11.93
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 11.93
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 11.89
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 11.87
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 11.87
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 11.86
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 11.86
Chromatin landscape of human visceral and subcutaneous adipocytes 11.82
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 11.77
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 11.77
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 11.76
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 11.56
RNA sequencing analysis of selumetinib-resistant CRC cells lines 11.42
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 11.02
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 10.98
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 10.87
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 10.78
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 10.72
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 10.63
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 10.52
mRNA-Seq profiling of human developing kidney 10.46
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 10.35
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 10.3
AUF-1 affected genes in human skin cells 10.22
Functional astrocytes differentiated from hiPSCs 10.17
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 9.96
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 9.92
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 9.92
Fusion discovery in breast cancer cell line 9.76
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 9.76
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 9.69
RNA-Seq of Breast and Ovarian Cancer Cell Lines 9.66
Epigenome regulation during epidermal lineage commitment [RNA-seq] 9.65
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 9.61
circRNA profile in hypopharyngeal cancer 9.56
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 9.35
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 9.35
Gene expression profile difference among renal location in a stone former 9.32
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 9.03
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 9.03
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 9.02
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 8.94
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 8.94
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 8.93
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 8.9
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 8.84
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 8.84
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 8.71
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 8.57
Dynamic reorganization of nuclear architecture during human cardiogenesis 8.57
Proteomics identifies a marker signature of MAPKi resistance in melanoma 8.42
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 8.07
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 8.04
Subtle asymmetry of gene expression in embryonic and foetal human brains 7.97
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 7.97
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 7.9
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 7.88
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 7.84
Effect of drugs on transcriptomic profiles 7.75
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 7.51
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 7.41
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 7.41
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 7.26
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 6.91
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 6.88
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 6.74
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 6.72
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 6.7
Zika virus infection reprograms global transcription of host cells to allow sustained infection 6.64
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 6.49
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 6.47
A transcriptome dataset revealing the molecular features of breast cancer stem cells 6.33
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 6.18
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 6.06
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 5.98
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 5.97
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 5.96
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 5.96
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 5.86
Argonaute proteins couple chromatin silencing to alternative splicing 5.8
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 5.8
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 5.75
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 5.69
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 5.58
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 5.52
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 5.46
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 5.41
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 5.33
CDK4/6 inhibitor resistance in prostate cancer 5.28
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 5.27
Human ovarian granulosa cell transcriptome 5.21
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 5.2
Molecular analysis of renal cell carcinoma with unclassfied histology 5.2
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.18
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.18
Metabolism as an early predictor of DPSCs aging 5.17
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 4.91
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 4.9
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 4.89
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 4.56
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 4.54
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 4.53
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 4.44
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 4.44
mRNA differential expression analysis in a human ex vivo model of chronic wounds 4.36
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 4.34
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 4.33
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 4.33
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 4.28
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 4.1
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 4.01
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 3.95
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 3.88
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 3.85
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 3.79
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 3.76
Gene expression profile of CRC-derived HILEC 3.76
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 3.73
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 3.73
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 3.65
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 3.63
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 3.61
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 3.5
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 3.44
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 3.38
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 3.36
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 3.12
RNA-seq data 3.0
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.98
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 2.78
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 2.71
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 2.68
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 2.68
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 2.63
Fibroblasts in cholesteatoma activate osteoclasts. 2.63
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 2.6
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 2.55
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 2.55
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 2.5
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 2.45
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 2.3
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 2.27
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 2.24
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 2.05
BMS-470539 on human synovial fibroblasts 2.01
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 1.96
Gene expression of thyroid cancer cell lines 1.87
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.87
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.64
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.55
Transcriptome profiling of 5 human adenocarcinoma cell lines 1.5
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 1.5
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 1.45
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.4
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 1.37
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.1
Identification of differentially expressed genes between senescence and senescence bypass cells 1.05
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 1.05
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 1.05
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.04
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.96
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.95
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.9
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 0.81
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 0.81
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.8
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.8
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.76
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 0.52
Loss of endometrial plasticity in recurrent pregnancy loss 0.52
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 0.51
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.46
mRNA sequencing of oropharyngeal cancer cell lines 0.42
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.24
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.22
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.22
hNSCs siRNA NOVA2 0.17
KSDM1b Role in Ewing Sarcoma 0.08


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation